Orbus Therapeutics Funding: $90M Raised, Series A (2020)
Orbus Therapeutics is based in Palo Alto. It has raised $90M in total funding. Latest round: Series A.
Orbus Therapeutics funding overview
Orbus Therapeutics is based in Palo Alto. Orbus Therapeutics has raised $90M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in October 2020. The round record for Orbus Therapeutics runs through 2020; nothing later has been disclosed. Investors on record include Adams Street Partners, H.I.G. BioHealth Partners, Longitude Capital, BioHealth Partners. 4 distinct backers are named across the disclosed rounds.
Orbus Therapeutics at a glance
Total raised
$90M
Latest round
Series A
Latest round date
October 2020
Headquarters
Palo Alto
Notable investors
Adams Street Partners, H.I.G. BioHealth Partners, Longitude Capital, BioHealth Partners
Frequently asked about Orbus Therapeutics funding
How much has Orbus Therapeutics raised?
Orbus Therapeutics has raised $90M in total disclosed funding across the rounds on record.
Who has invested in Orbus Therapeutics?
Adams Street Partners, H.I.G. BioHealth Partners, Longitude Capital, BioHealth Partners are named among the investors backing Orbus Therapeutics.
What was the latest Orbus Therapeutics funding round?
The most recent disclosed round is a Series A, announced in October 2020.
Where is Orbus Therapeutics based?
Orbus Therapeutics is based in Palo Alto.
When did Orbus Therapeutics last raise?
The last disclosed Orbus Therapeutics round closed in October 2020 at Series A.
Every Orbus Therapeutics figure above comes from filings and announced rounds in the StartupFundraising company database and is revised as new rounds are recorded. The lists below compare companies in Palo Alto at a similar stage.
